Aller au contenu principal
Profil bibliographique

Sung Won Choi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées
144Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchRenal Transplantation Outcomes and TreatmentsChronic Lymphocytic Leukemia Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Qualitative Analysis of User Experiences of a mHealth Self-Care Intervention for Care Partners of Individuals with Traumatic Brain Injury

Rongqi Bei, Christopher M. Graves, Sung Won Choi, Angelle M. Sander et autres

Objective: To identify challenges and solutions for conducting mobile health (mHealth) research in a rehabilitation care partner population that involved personalized self-care push notifications and self-monitoring data collection. Design: Qualitative semistructured debriefing interviews with participants who completed a 6-month app-based self-care intervention …

us, no (code pays fourni par la source)

0 citations Archives of Rehabilitation Research and Clinical Translation
Accès ouvert 2026 preprint OpenAlex

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study

Jakob Wirbel, Wael Saber, Michael J. Martens, Jonathan U. Peled et autres

Abstract Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment for many hematological malignancies, but graft-versus-host disease (GVHD) is a common complication. Low gut microbiome diversity is associated with higher GVHD risk and shorter survival in multiple studies. Recently, the BMT …

de, us (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2025 conference-abstract OpenAlex

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study

Monzr M. Al Malki, Stephanie Bo‐Subait, Brent R. Logan, Sarah Smith et autres

Abstract Allogeneic hematopoietic cell transplantation (HCT) remains inaccessible to many patients, particularly those of non-European ancestry, due to the limited availability of matched unrelated donors (URD). While single-HLA mismatched donors (7/8) often yield acceptable outcomes, URD HCT mismatched at ≥ 2 HLA …

us, qa, nl (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 conference-abstract OpenAlex

Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study

Mahasweta Gooptu, Monzr M. Al Malki, Stephanie Bo‐Subait, Brent R. Logan et autres

Abstract Allogeneic hematopoietic cell transplantation (HCT) using an HLA mismatched unrelated donor (MMUD) with calcineurin inhibitor-based graft versus host disease (GVHD) prophylaxis results in increased incidence of non-relapse mortality (NRM) and lower survival compared to matched donor HCT. The NMDP sponsored 15-MMUD …

us, qa, nl (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 preprint OpenAlex

Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant

Steven J. Siegel, Susan DeWolf, Joseph Schmalz, Wael Saber et autres

Successful hematopoietic cell transplant requires immunosuppression to prevent graft-versus-host disease (GVHD), a lethal, T-cell-mediated post-transplant complication. The phase 3 BMT CTN 1703 trial demonstrated superior GVHD-free/relapse-free survival for post-transplant cyclophosphamide (PT-Cy)-based GVHD prophylaxis versus tacrolimus/methotrexate (Tac/MTX), but did not improve overall survival. …

us, Afrique du Sud (code pays fourni par la source)

8 citations medRxiv
Accès ouvert 2025 article OpenAlex

Impact of Post-Consolidation MIBG (Curie) Scores on Outcomes Following Autologous Transplantation in High-Risk Neuroblastoma

Erin Hamanishi, Tzu-Hsuan Lin, Chelsea Honstain, Susan Murray et autres

Introduction The utility of a semi-quantitative MIBG scoring system (i.e. Curie scoring, CS), has previously been validated at the time of diagnosis and end-induction in high-risk neuroblastoma therapy. To date, the impact of CS post-transplant has not been reported. We now examine …

us (code pays fourni par la source)

0 citations Transplantation and Cellular Therapy
Accès ouvert 2020 article OpenAlex

Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia

Anna Hecht, Julia A. Meyer, Astrid Behnert, Eric B. Wong et autres

Mutations in the gene CBL were first identified in adults with various myeloid malignancies. Some patients with juvenile myelomonocytic leukemia (JMML) were also noted to harbor mutations in CBL, but were found to have generally less aggressive disease courses compared to other …

us, de, ca (code pays fourni par la source)

49 citations Haematologica
Accès ouvert 2019 article OpenAlex

Vestibular Rehabilitation Using Virtual Reality Technology

Sung Won Choi, Hyun Min Lee

In Republic of Korea, the number of patients complaining of dizziness is continuously increasing. Vestibular rehabilitation is known to be an effective and safe treatment method for dizzy patients, especially in unilateral vestibular hypofunction. Recently, various literatures about applying virtual reality (VR) …

Éthiopie, kr, pr, us (code pays fourni par la source)

0 citations Journal of Clinical Otolaryngology Head and Neck Surgery
Accès ouvert 2019 article OpenAlex

Ultrasensitive Genomic Minimal Residual Disease Detection in Peripheral Blood after Allogeneic HSCT for MDS Is Associated with Increased Relapse Risk and Inferior Survival

Brian Parkin, L.E. Thompson, Ryan Nazareno, Alyssa Clearwood et autres

Introduction Genomic minimal residual disease (MRD) detected in complete remission using droplet digital PCR (ddPCR) is associated with inferior survival in AML patients when measured after induction chemotherapy and before and after allogeneic HSCT. However, the utility of high sensitivity genomic MRD …

us (code pays fourni par la source)

0 citations Transplantation and Cellular Therapy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.